Herbs (Global Traditional) · African
Sutherlandia (Lessertia frutescens) (Lessertia frutescens)
Moderate Evidencebotanical3 PubMed Studies
Hermetica Superfood Encyclopedia
Sutherlandia (Lessertia frutescens) contains the cyclitol pinitol, which may enhance glucose uptake and utilization in cells, potentially supporting blood sugar regulation. It also possesses triterpenoid saponins that demonstrate preliminary antiproliferative effects against cancer cell lines in laboratory studies.
Sutherlandia frutescens, also known as Lessertia frutescens, is a woody perennial shrub in the legume family native to southern Africa, commonly called 'Cancer Bush' or 'Balloon Pea.' The herb is typically supplied as dried leaf and stem material, used mainly as an aqueous infusion or decoction for internal consumption or external application.
The available research consists primarily of in vitro studies and preliminary laboratory research, with no human clinical trials, randomized controlled trials, or meta-analyses identified in the provided literature. One study evaluated crude aqueous extracts in a 3D spheroid model showing cytotoxic effects, but this represents laboratory research rather than clinical evidence in human subjects.
Traditional dosing suggests half a bunch (approximately 10 grams, equivalent to 3 tablespoonsful) of dried material prepared as an infusion or decoction. Laboratory studies used 1:10 plant-to-liquid ratios in water (10 g raw powder in 100 mL distilled water) with stock solutions of 8 mg/mL. Standardized extract dosages for human use have not been established in clinical studies. Consult a healthcare provider before starting any new supplement.
Sutherlandia (Lessertia frutescens) is not consumed as a food for macronutrient value but rather as a medicinal herb; its significance lies in its bioactive compound profile. Key compounds include: **L-canavanine** (a non-protein amino acid arginine analogue, approximately 1.0–3.0% dry weight in leaf material), which has demonstrated antiproliferative and antiviral properties in vitro; **D-pinitol** (a cyclitol/methyl-inositol, approximately 1.0–1.5% dry weight), an insulin-mimetic compound that may enhance cellular glucose uptake; **GABA (gamma-aminobutyric acid)** (approximately 0.6–1.4% dry weight), an inhibitory neurotransmitter precursor associated with anxiolytic and calming effects; and **SU1 (a cycloartane glycoside/triterpenoid saponin)** identified as a marker compound with potential anti-inflammatory activity. The plant also contains flavonoids and flavonol glycosides (including kaempferol and quercetin derivatives), contributing antioxidant capacity with ORAC values reported in moderate ranges for dried leaf preparations. Minor amounts of asparagine, proline, and other free amino acids have been detected. Triterpene saponins (including sutherlandiosides A–D, at varying concentrations typically quantified at 0.01–0.2% dry weight collectively) and flavonoid glycosides (sutherlandins A–D) serve as key quality control markers. The herb provides trace minerals including iron, zinc, magnesium, calcium, and potassium, though concentrations are relatively low and variable depending on soil and growing conditions. Vitamin content is minimal and not nutritionally significant. Bioavailability notes: L-canavanine is orally bioavailable but competes with arginine in protein synthesis, raising safety concerns at high doses; D-pinitol shows reasonable oral bioavailability in human studies; GABA from oral ingestion has limited blood-brain barrier permeability, though peripheral effects may still occur; triterpenoid saponins generally have low oral bioavailability but may exert local gastrointestinal effects and undergo hepatic metabolism. Most traditional preparations are aqueous infusions or decoctions (teas), which preferentially extract polar compounds like pinitol, GABA, and canavanine over less polar triterpenoids.
Pinitol, an inositol derivative in Sutherlandia, is hypothesized to act as an insulin mimetic, facilitating glucose transport into cells and increasing cellular glucose utilization. Triterpenoid saponins, known as sutherlandiosides, and L-canavanine demonstrate antiproliferative and pro-apoptotic effects on various cancer cell lines by disrupting cell cycle progression and inducing programmed cell death. These compounds also contribute to its traditional adaptogenic and immunomodulatory properties.
Research on Sutherlandia (Lessertia frutescens) primarily consists of in vitro studies and animal models, with limited human clinical trials. In laboratory settings, extracts have shown antiproliferative effects against various cancer cell lines, although specific outcomes and dosages are not yet established in human subjects. Preclinical studies suggest pinitol's role in glucose metabolism, but robust clinical evidence demonstrating significant blood sugar regulation in humans is currently lacking. Overall, more extensive, well-designed human clinical trials are required to confirm its efficacy and safety for specific health conditions.
Sutherlandia is generally considered well-tolerated at traditionally used dosages; however, mild gastrointestinal upset, dizziness, or dry mouth have been reported in some individuals. Due to its potential blood sugar-lowering effects, caution is advised for individuals on antidiabetic medications, as it may potentiate hypoglycemic events. There is insufficient data regarding its safety during pregnancy and lactation, thus its use is contraindicated in these populations. Individuals with autoimmune conditions should consult a healthcare professional due to its potential immunomodulatory effects.
